Research conducted at the University of Minnesota Twin Cities and published in Nature Communications demonstrated that engineered immune cells used as new cancer therapy allows the patient's own immune system to fight tumors. The research could help improve cancer therapies in the future for millions of people worldwide. Immunotherapy deals with utilizing the body’s defense mechanism against cancer cells. The role of cytotoxic T-cells is very crucial in the immune system as they identify and destroy targeted invader cells.
Immunotherapy has already demonstrated good outcomes in the cancers of blood and blood organs, but T-cells act differently when it comes to solid tumors. In a tumor, the maneuverability of T-cells is compromised due to tumor stiffness, and they are unable to reach the target cancer cells. In this first-of-its-kind study, the researchers engineered the T-cells and…
